VERA
Vera Therapeutics, Inc.
13.79
USD
This page is just a preview of the data found in TrendSpider’s full version
Vera Therapeutics, Inc. stock is up 19.81% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 1 PUT, 1 CALL. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 10 Oct 19:19 | 17 Nov, 2023 | 10.00 | 303 | ||
| 10 Nov 19:58 | 15 Dec, 2023 | 17.50 | 540 |
Vera Therapeutics, Inc. focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for immunoglobulin A nephropathy.
